Cialis Every Other Day: Potential Effects on Blood Flow

Tadalafil, the active ingredient in Cialis, has a half-life long enough that taking it every other day still maintains meaningful drug levels in the bloodstream, and at least one head-to-head comparison found alternate-day dosing produced improvements in erectile function and urinary symptoms that were close to those of daily dosing. But the blood-flow story goes well beyond the penis. Research over the past two decades has explored how sustained tadalafil use influences circulation in arteries, the heart, the brain, the eyes, and even the skin, with results that range from clearly beneficial to surprisingly nuanced.

Why Every-Other-Day Dosing Stays Active

Tadalafil stands apart from other drugs in its class because of how slowly the body clears it. Its half-life sits around 17.5 hours, meaning that roughly half the drug remains in your system nearly a full day after you swallow a tablet.¹ With daily dosing, drug levels accumulate to a steady state. With every-other-day dosing, levels rise and fall in a shallow wave rather than flatline, but they never drop to zero before the next dose arrives. That pharmacokinetic profile is the whole reason alternate-day regimens are even worth studying: the drug is still doing something vascular on the “off” day.

How Alternate-Day Compares to Daily Dosing

A trial comparing 5 mg tadalafil taken daily against the same dose taken every other day in men with both erectile dysfunction and lower urinary tract symptoms found that both schedules improved erectile function scores, successful intercourse rates, and symptom scores over the study period. The daily group had a slight edge in erectile function scores at the midpoint visit, but the differences were modest. Both regimens were well tolerated, and the researchers concluded that alternate-day dosing could be adequate for regular use.² A separate meta-analysis looking at longer treatment cycles found that daily tadalafil had a statistically greater improvement in erectile function domain scores and successful intercourse rates compared with on-demand use, while on-demand dosing actually had a higher incidence of any treatment-related side effect.³ The practical takeaway is that every-other-day dosing occupies a middle ground: less drug exposure and potentially fewer side effects than daily use, with outcomes that still track reasonably close.

What Tadalafil Does Inside Blood Vessels

Tadalafil works by blocking an enzyme called PDE5 that normally breaks down a signaling molecule (cGMP) responsible for relaxing smooth muscle in blood vessel walls. When PDE5 is inhibited, cGMP accumulates, smooth muscle relaxes, and the vessel widens. That is the basic mechanism behind erections, but the same enzyme is present in arteries throughout the body, which is why tadalafil’s vascular reach extends far beyond the pelvis.

Animal research has shown that tadalafil preserves the enzymes that produce nitric oxide, the upstream trigger for the whole relaxation cascade. In rats exposed to a drug that damages penile nerve signaling, tadalafil treatment kept neuronal nitric oxide synthase levels significantly higher than in untreated animals, and it normalized the levels of endothelial and inducible forms of the same enzyme.⁴ That matters because nitric oxide is not just a one-time chemical signal; chronic depletion of the enzymes that make it leads to stiffening and damage in blood vessel walls over time.

In humans, a trial of men at increased cardiovascular risk showed that four weeks of tadalafil roughly doubled flow-mediated dilation of the brachial artery, a standard test of how well the inner lining of arteries responds to increased blood flow. The improvement persisted at a six-week follow-up, while the placebo group showed no change at all.⁵ However, one randomized trial in men with erectile dysfunction found that brachial artery dilation improved about equally in both the tadalafil and placebo groups after four weeks, with no significant difference between the two arms.⁶ And another daily-dosing study found no significant differences in biomarkers of endothelial dysfunction or peripheral arterial tone measurements between the treatment and placebo groups.⁷ The mixed results suggest that tadalafil’s endothelial benefits may depend heavily on how much vascular damage already exists: people with clear endothelial dysfunction at baseline seem to gain more than those with healthier arteries.

Arterial Stiffness and Blood Pressure

Arterial stiffness is an independent risk factor for cardiovascular disease, and there is evidence that tadalafil can soften things up. A study of men taking tadalafil for urinary symptoms measured brachial-ankle pulse wave velocity, a gauge of how quickly pressure waves travel through stiff arteries. After ten weeks of daily tadalafil, pulse wave velocity dropped meaningfully, and a separate index of vascular endothelial function climbed in parallel.⁸ A similar study in men with benign prostatic hyperplasia found that pulse wave velocity improved from three months onward and remained improved through a full year of follow-up, while the ankle-brachial index, a marker of peripheral artery health, improved at six months.⁹

Meanwhile, a randomized trial looking at circulating biomarkers found that tadalafil reduced endothelin-1, a potent vasoconstrictor, and tissue plasminogen activator in men with erectile dysfunction and vascular risk factors, though the overall effect on endothelial markers was described as modest.¹⁰ A larger trial of 306 men found more robust, dose-dependent changes: both the 2.5 mg and 5 mg daily doses raised eNOS levels and reduced several inflammatory and endothelial-damage markers over 12 weeks.¹¹

Heart Safety and Coronary Blood Flow

For anyone with heart disease who is considering regular tadalafil, the question of coronary blood flow is front and center. The evidence here is reassuring. In men with documented coronary artery disease, tadalafil did not change the time it took for exercise to provoke signs of heart-muscle oxygen deprivation compared with placebo.¹² A separate imaging study measured actual blood flow within the heart muscle during rest, during chemical stress that mimics exercise, and during dobutamine stimulation. Tadalafil did not significantly change resting or chemical-stress blood flow. During dobutamine infusion, blood flow in healthy heart segments was slightly higher with tadalafil than with placebo, and there was a trend in the same direction for abnormal segments, though the latter did not reach statistical significance.¹³ In plain terms, tadalafil does not appear to “steal” blood away from heart tissue that already has restricted supply, a theoretical concern with any vasodilator.

Interactions With Blood Pressure Medications and Nitrates

The most important safety issue with tadalafil and blood flow is the interaction with nitrate drugs such as nitroglycerin. A detailed pharmacokinetic study showed that when nitroglycerin was given 4, 8, or 24 hours after a tadalafil dose, more subjects experienced drops in standing systolic blood pressure below 85 mmHg compared with placebo. By 48 hours and beyond, there was no longer any meaningful difference.¹⁴ This is especially relevant for every-other-day dosing: the drug is still active enough on the day between doses to interact dangerously with nitrates. Combining any PDE5 inhibitor with nitrates can cause a large, potentially dangerous drop in blood pressure, and tadalafil is also contraindicated with alpha-blocker medications except for tamsulosin at its lowest dose.¹⁵

What about routine blood pressure drugs that are not nitrates? A large real-world observational study compared periods when patients possessed both tadalafil and antihypertensive medications against periods when they had antihypertensives alone. Rates of diagnosed hypotension and ventricular arrhythmia were actually lower during the combined periods, and the study found no increased cardiovascular risk from the combination.¹⁶ The nitrate prohibition stands firm, but standard blood pressure medications appear to coexist safely with tadalafil.

Pelvic and Prostatic Blood Flow

Erectile dysfunction and bothersome urinary symptoms from an enlarged prostate frequently appear together, and a growing body of research suggests that both problems share a root cause in pelvic microvascular dysfunction. The theory is that reduced blood flow to the bladder, prostate, and penis triggers a cycle of oxygen deprivation, abnormal smooth-muscle contraction, and nerve degeneration that worsens both conditions.¹⁷ In a rat model of chronic pelvic ischemia, tadalafil prevented the increased contractile response, collagen buildup, and smooth muscle changes that normally occur in oxygen-starved prostate tissue.¹⁸ This helps explain why tadalafil is approved for both erectile dysfunction and benign prostatic hyperplasia: it may be addressing the shared vascular deficit underneath both conditions.

Circulation in the Hands, Feet, and Skin

Tadalafil’s vascular effects extend to the body’s periphery in ways that have nothing to do with sexual function. Raynaud’s phenomenon, a condition where small arteries in the fingers and toes spasm painfully in response to cold or stress, responds to PDE5 inhibitors. A double-blind crossover trial in patients with secondary Raynaud’s who had not responded to other vasodilators found that tadalafil significantly reduced the daily frequency and duration of attacks, healed all 24 existing digital ulcers during the treatment phase compared to only a few during placebo, and improved flow-mediated dilation and quality of life.¹⁹ A case report documented a patient whose Raynaud’s symptoms did not respond to sildenafil but improved with tadalafil, with laser Doppler confirming increased blood flow.²⁰

The wound-healing space holds some striking anecdotes. One case report described a patient whose severe chronic foot wound, present for 50 years following a traumatic injury and resistant to every intervention including multiple surgeries, underwent near-complete resolution after starting daily tadalafil for an unrelated urological issue. The wound remained stable for two years.²¹ More controlled evidence comes from a porcine burn model, where daily oral tadalafil shortened the time to complete skin regrowth by roughly a week and reduced scar depth by about a millimeter and a half compared to controls.²² These findings are early-stage, but they point toward a plausible mechanism: better perfusion to damaged tissue means faster healing.

Brain Blood Flow

Cerebrovascular effects are where the picture gets complicated. A pilot study in patients who had recently experienced a small-vessel stroke found that a single dose of tadalafil appeared to initially lower cerebral blood flow velocity in the middle cerebral artery at 30 and 90 minutes compared to placebo, but by three hours, cerebral tissue oxygen saturation had increased.²³ A separate study found that after both single-dose and continuous tadalafil administration in stroke patients, areas of reduced regional cerebral blood flow appeared in the affected hemisphere.²⁴ These seemingly contradictory findings may reflect different measurement methods and time windows, but they underscore that the brain’s vascular response to PDE5 inhibition is not a simple case of “more drug, more flow.” The cerebral vasculature has its own autoregulatory systems, and how those interact with tadalafil is still being worked out.

Effects on the Eyes

PDE5 is present in retinal and choroidal blood vessels, and tadalafil does influence ocular circulation. A study using optical coherence tomography angiography found that on the first day after starting tadalafil, choroidal thickness in the area beneath the macula increased by about 14 percent, and vascular density of both superficial and deep retinal capillary layers rose by roughly 10 percent. By three months, those increases had partially retreated, though choroidal thickness had not fully returned to baseline. Retinal ganglion cell thickness remained unchanged at both time points.²⁵

Interestingly, a study comparing long-term tadalafil users to non-users found that users actually had significantly lower vascular density in several retinal layers and in the radial peripapillary capillary network around the optic disc, while the deepest choroidal layer showed no difference.²⁶ That finding does not necessarily mean tadalafil is damaging retinal vessels; the clinical significance is unclear, and vision was not affected. But rare ocular complications have been reported. PDE5 inhibition causes vasodilation and increased permeability in choroidal blood vessels, which has been linked in case reports to central serous chorioretinopathy, a condition where fluid accumulates beneath the retina.²⁷ Anyone noticing sudden vision changes while taking tadalafil on any schedule should get it checked promptly.

Muscle Blood Flow During Exercise

In healthy athletes, a single dose of tadalafil before anaerobic exercise did not change peak power, mean power, or most performance metrics. The one exception was that blood lactate levels at three-minute recovery were slightly higher with tadalafil, and time to peak power was slightly shorter, suggesting some modest shift in how muscles handled intense effort, even though overall output did not change.²⁸

The picture looks very different in people with a specific muscle disease. In men with Becker muscular dystrophy, where a genetic defect disrupts the normal ability of exercising muscles to override sympathetic vasoconstriction and maintain blood flow, a single dose of tadalafil fully restored normal blood flow regulation to exercising muscle. The drug essentially bypassed the broken signaling step by boosting the downstream pathway that relaxes blood vessels during exertion.²⁹ This is a compelling example of how tadalafil’s blood-flow effects can be dramatic in people with a specific underlying vascular deficit while being barely detectable in healthy individuals.

Kidney Protection

Chronic kidney disease involves progressive scarring and loss of filtering capacity, and impaired blood flow plays a role in driving that damage. In a rat model of kidney disease induced by a high-salt diet, both low- and high-dose tadalafil reduced markers of kidney injury, including lower serum creatinine and urinary protein levels. Tadalafil also reduced the scarring of glomeruli (the kidney’s filtering units) and suppressed a key pro-fibrotic signal. Only the higher dose affected blood pressure itself, suggesting that the kidney-protective effects operated partly through a local vascular mechanism rather than just by lowering systemic pressure.³⁰ This is animal data, not a clinical recommendation, but it adds to the broader theme: PDE5 inhibition appears to reduce ischemic damage wherever it occurs in the body.

Effects on Platelets and Clotting

Blood flow is not just about vessel diameter; it also involves how freely blood moves without clumping. Tadalafil has been shown to inhibit platelet activation, increase platelet cGMP levels, and reduce markers of inflammation with daily use at the standard 5 mg dose.³¹ Platelets express PDE5, so the same inhibition that relaxes vessel walls also dampens the tendency of platelets to clump together. Whether this translates into meaningful protection against blood-clot-driven events like heart attack or stroke is an open question with no definitive clinical trial answer yet, but the mechanistic plausibility is there.

What Every-Other-Day Dosing Means in Practice

If you are considering every-other-day tadalafil, the most relevant thing to understand is that the drug’s blood-flow effects do not switch on and off like a light. On the day you take it, levels peak within a couple of hours and then gradually decline. By the next day, you still have meaningful drug levels circulating. By the time you take the next dose roughly 48 hours later, levels have dropped further but not to zero, and the cycle resets. The vascular effects described throughout this article, from endothelial improvements to arterial-stiffness reductions to peripheral vasodilation, all depend on having enough drug present to maintain PDE5 inhibition. Alternate-day dosing maintains that inhibition most of the time, though at fluctuating levels rather than the steady plateau of daily dosing.

The nitrate interaction window is something to think through carefully with this schedule. Because tadalafil’s blood-pressure-lowering interaction with nitroglycerin persists for at least 24 hours after a dose, an every-other-day schedule does not create a reliably “safe” window for nitrate use on the off day.¹⁴ Anyone prescribed nitroglycerin or other nitrate medications should not use tadalafil at any dosing frequency without explicit guidance from a cardiologist.